Manufacturers

Soterix Medical Inc.

237, w 35th Street 1401 , 10001 New York
USA

Telephone +1 888 9908327
Fax +1 212 3153232
contact@soterixmedical.com

Trade fair hall

  • Hall 11 / A11
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 11): stand A11

Fairground map

MEDICA 2016 fairground map: Hall 11

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.03  Therapie and physical medicine
  • 01.03.10  Stimulation equipment for diagnostics / therapy

Stimulation equipment for diagnostics / therapy

Our products

Product category: Stimulation equipment for diagnostics / therapy

The Soterix Medical tDCS Advantage

In 2008, when Soterix Medical was founded to support clinical research on tDCS, no device included features designed for tDCS, no electrodes designed for consistent tDCS were available, head-gear was limited to rubber-bands, and researchers did not have access to any software to guide current to targeted regions. Today, Soterix Medical continues to set the standard for design and innovation in tDCS.

Clinicians and researchers choose the Soterix Medical 1×1 systems to:

  1. Ensure reproducible and precise stimulation operation across subjects and time.
    When precision cannot be compromised, leading clinical investigators choose Soterix Medical 1x1 products. Each device is optimized to produce consistent output and performance. With Soterix Medical you can worry about your study design and your subjects, knowing the device is engineered to the highest medical standards.
  2. Provide for simple and comfortable set-up and stimulation.
    The 1x1 platform of devices, software, and accessories are uniquely designed for tDCS with rational optimization to your study. One size does not fit all. For each application Soterix Medical engineer consulted with clinical leaders to determine the best practices and optimal stimulation settings. Each Soterix Medical device is further simplified to ease of use and robust operation - one looks at our device designs and the focus on usability is clear.
  3. Conduct clinical studies with state-of-the-art control and safety features.
    Advancing the practice of tDCS requires devices and protocols integrating the latest advances in technology and science. Soterix Medical was founded to support this effort and continues to provide unparalleled support to every user. Devices and accessories incorporate exclusive features for rigorous trial design, tolerated procedures, and reproducible protocols*.

*Soterix Medical does not provide consulting or support on technologies, including electrodes and dose guidelines, not produced or explicitly endorsed for compatibility by Soterix Medical or our authorized distributors. For tDCS concerns not using the 1x1 platform and accessories, please contact your vendor directly.

More Less

About us

Company details

Soterix Medical Inc. (SMI) was formed to develop and deploy innovative medical treatments focused on neuropsychiatric and neurological disorders and rehabilitation. Founded in 2008, SMI is the world leader in clinical trials for non-invasive neuromodulation working with over 250 medical centers in the US and worldwide. SMI has licensed and developed a comprehensive intellectual property portfolio that includes High-Definition transcranial Direct Current Stimulation (HD-tDCS), Limited Total Energy tDCS (LTE-tDCS), and Neurotargeting. From the most targeted non-invasive clinical systems to the most portable units, Soterix Medical provides clinicians and patients with unique and adaptable solutions. Ongoing Phase I, II, IIb, and III trials use investigational devices that are regulated/limited by US or Federal law. SMI is proudly based in New York City with international distributors in all major markets.

More Less